LAHRS Content 2023-Optimal Device Implantation Techniques

Video Transcription

Video Summary

In summary, the management of ventricular tachycardia (VT) in patients with structural heart disease presents a challenge, with a high risk of VT recurrence. While implantable cardioverter defibrillators (ICDs) are still considered necessary, they do not target the underlying cause or effectively treat arrhythmia induction. Evidence suggests that catheter ablation as a first-line treatment for recurrent VT before ICD implantation can result in improved outcomes. By targeting the areas of abnormal tissue associated with VT, ablation can help reduce VT recurrence and related events such as hospitalization and death. Ultimately, a combination of ICD and ablation may be the optimal approach for managing VT in patients with structural heart disease.

Keywords

ventricular tachycardia

structural heart disease

management

implantable cardioverter defibrillators

ICDs

catheter ablation

recurrent VT

arrhythmia induction

abnormal tissue

hospitalization